Literature DB >> 17408525

The minor allele of the PPARgamma2 pro12Ala polymorphism is associated with lower postprandial TAG and insulin levels in non-obese healthy men.

Ulf Helwig1, Diana Rubin, Julia Kiosz, Stefan Schreiber, Ulrich R Fölsch, Michael Nothnagel, Frank Döring, Jürgen Schrezenmeir.   

Abstract

The PPARgamma Pro12Ala polymorphism has been associated in several studies with a decreased risk of obesity, type 2 diabetes and insulin resistance. Weak hints are available about the influence of PPARgamma Pro12Ala on postprandial metabolism. In 708 men, aged 45 to 65 years the PPARgamma2 Pro12Ala genotypes were determined and postprandial TAG, insulin, glucose and NEFA after a standardized mixed fat meal and insulin and glucose after a glucose load (oral glucose tolerance test; OGTT) were assessed. Using the total sample, we did not find a significant impact of the genotype on the postprandial metabolism. In the subgroup with BMI <30 kg/m2, fasting and postprandial TAG and insulin levels as well as homeostasis model assessment of insulin resistance (HOMA) were significantly lower in the Ala12Ala group than in the Pro12Pro group after the mixed meal. In contrast, the groups did not differ in insulin levels and HOMA after the OGTT. To investigate if differences between a fat-containing meal and OGTT are caused by adiponectin, we examined a BMI- and age-matched subgroup. No differences were found between the genotypic groups. The effects of the PPARgamma2 polymorphism on insulin sensitivity are mediated by affluent dietary fat. We did not find evidence that adiponectin as a fatty-acid-dependent adipocyte factor is a causative factor for this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408525     DOI: 10.1017/S0007114507665179

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  6 in total

1.  Influence of different CLA isomers on insulin resistance and adipocytokines in pre-diabetic, middle-aged men with PPARγ2 Pro12Ala polymorphism.

Authors:  Diana Rubin; Julia Herrmann; Daniela Much; Maria Pfeuffer; C Laue; P Winkler; Ulf Helwig; Doris Bell; Annegret Auinger; Stephanie Darabaneanu; Andreas Ruether; Jürgen Schrezenmeir
Journal:  Genes Nutr       Date:  2012-03-08       Impact factor: 5.523

2.  G Allele of the rs1801282 Polymorphism in PPARγ Gene Confers an Increased Risk of Obesity and Hypercholesterolemia, While T Allele of the rs3856806 Polymorphism Displays a Protective Role Against Dyslipidemia: A Systematic Review and Meta-Analysis.

Authors:  Shujin Li; Chuan He; Haiyan Nie; Qianyin Pang; Ruixia Wang; Zhifu Zeng; Yongyan Song
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

3.  Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach.

Authors:  Maira Ladeia R Curti; Patrícia Jacob; Maria Carolina Borges; Marcelo Macedo Rogero; Sandra Roberta G Ferreira
Journal:  J Obes       Date:  2011-05-23

4.  Association of the variants in the PPARG gene and serum lipid levels: a meta-analysis of 74 studies.

Authors:  Qing Li; Rong Chen; Lizhan Bie; Dandan Zhao; Chunkai Huang; Jiang Hong
Journal:  J Cell Mol Med       Date:  2014-09-30       Impact factor: 5.310

5.  PPARγ2 polymorphism and human health.

Authors:  Weimin He
Journal:  PPAR Res       Date:  2009-04-16       Impact factor: 4.964

6.  Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARgamma2 P12A polymorphism: a double blind, randomized, controlled cross-over study.

Authors:  J Herrmann; D Rubin; R Häsler; U Helwig; M Pfeuffer; A Auinger; C Laue; P Winkler; S Schreiber; D Bell; J Schrezenmeir
Journal:  Lipids Health Dis       Date:  2009-08-18       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.